Skip to main content
INNOVA CAPTAB LIMITED logo

INNOVA CAPTAB LIMITED — Investor Relations & Filings

Ticker · INNOVACAP ISIN · INE0DUT01020 LEI · 549300SNL5HFUHE66804 BSE.NS Manufacturing
Open in API
Filings indexed 208 across all filing types
Latest filing 2026-05-25 Board/Management Inform…
Country IN India
Listing BSE.NS INNOVACAP

About INNOVA CAPTAB LIMITED

https://www.innovacaptab.com

Innova Captab Limited is an integrated pharmaceutical company focused on the research, development, manufacturing, and marketing of a wide range of pharmaceutical formulations. The company operates primarily as a Contract Development and Manufacturing Organization (CDMO), providing comprehensive services to leading domestic and international pharmaceutical brands. Its product portfolio includes diverse dosage forms such as tablets, capsules, dry syrups, ointments, and injections across multiple therapeutic areas, including anti-infectives, analgesics, and gastrointestinal treatments. Innova Captab maintains a strong emphasis on R&D and quality control, operating advanced manufacturing facilities that adhere to global regulatory standards. In addition to its CDMO business, the company manages a domestic branded generics division and an international export business, catering to a global clientele with a focus on high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 30 of (read with Part A of Schedule III) and other applicable provisions SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ("Listing Regulations"), ....
Board/Management Information Classification · 92% confidence The document is a formal announcement to stock exchanges under SEBI Listing Regulations detailing outcomes of a Board Meeting held on 25th May 2026. It lists re-appointments of statutory, cost, and internal auditors, and the re-appointment of executive and non-executive directors. This clearly constitutes a Board/Management Information filing (changes and approvals made by the Board), matching our MANG category.
2026-05-25 English
Pursuant to regulation 30 (read with Part A Schedule III) and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), ....
Board/Management Information Classification · 90% confidence The document is an announcement of the outcome of a Board of Directors meeting under SEBI Listing Regulations. It details the re-appointment of statutory, cost, and internal auditors and, more importantly, the re-appointment of the Whole-Time Director, Managing Director, and Non-Executive Independent Directors. This is a corporate announcement concerning changes in the board and senior management, which falls under Board/Management Information (MANG).
2026-05-25 English
Outcome of Board Meeting
Board/Management Information Classification · 90% confidence The document is an official announcement under SEBI Listing Regulations detailing the outcome of a Board Meeting held on 25 May 2026. It primarily covers the re-appointment of statutory and cost auditors, internal auditors, and, most importantly, the re-appointment of the Whole-Time Director, Managing Director, and Non-Executive Independent Directors. This is clearly a change in the company’s board and senior management positions, fitting the definition of a Board/Management Information filing.
2026-05-25 English
Outcome of Board Meeting
Board/Management Information Classification · 90% confidence The document is a notice of the outcome of a Board Meeting under SEBI Listing Regulations, listing board approvals for re-appointments of statutory auditors, cost auditors, internal auditors, whole-time director, managing director, and independent directors, as well as approval of the AGM notice. It is not a full annual or quarterly report, earnings release, or proxy statement, but rather an announcement of board and management changes. Therefore, it fits the “Board/Management Information” category (MANG).
2026-05-25 English
Pursuant to regulation 30 (read with Part A of Schedule III) and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ('Listing Regulations'), ....
Board/Management Information Classification · 92% confidence The document is the formal outcome of a Board Meeting of Innova Captab Limited held on 25th May 2026. It is addressed to the stock exchanges under the SEBI Listing Regulations and details re-appointments of statutory, cost, and internal auditors, as well as the re-appointment of executive and non-executive directors for further terms. There is no financial data or earnings metrics (ruling out ER, IR, 10-K, etc.), nor is this a notice simply announcing the publication of a report (RPA), and it is not a proxy/solicitation, dividend notice, or other regulatory filing category. The primary content is announcements of board-level appointments and management changes, which falls squarely under Board/Management Information (MANG).
2026-05-25 English
Outcome of Board Meeting
Board/Management Information Classification · 85% confidence The document is a notice of the outcome of a Board Meeting pursuant to SEBI Listing Regulations, detailing the board’s approvals for re-appointments of statutory, cost, and internal auditors as well as re-appointments of executive and independent directors. This is an announcement of board/management changes rather than the report itself. Therefore, it falls under Board/Management Information.
2026-05-25 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.